***Background.*** We sought to prospectively evaluate the clinical impact of an Antibiotic Stewardship Program (ASP) focusing on treatment of UTI.

***Methods.*** Patients (pts) receiving ceftriaxone or ciprofloxacin for a suspected or documented UTI were followed during a pre-intervention (PRE; 10/13 to 12/13) and an intervention period (INT; 1/14 to 3/14). During INT, ASP staff reviewed the medical records of all pts with UTI five days per week and recommended therapeutic interventions (e.g., switch to a more appropriate agent, early antibiotic discontinuation). UTIs were categorized as uncomplicated and complicated infections as previously defined. Zero time (ZT) was defined as the day antibiotic therapy was initiated. The primary outcome was the rate of appropriate therapy as per current guidelines in each period; secondary outcomes included rates of antibiotic de-escalation, duration of therapy, subsequent new isolation of multidrug-resistant (MDR) organisms and pt outcomes within 30 days after ZT. Pts with concomitant infections or in hospice were excluded.

***Results.*** A total of 392 pts were included, 204 (52%) in PRE and 188 (48%) in INT. The median age of the total cohort was 74 years, 266 (68%) were female, and the median Charlson comorbidity score was 1. 252 (64%) pts had a complicated UTI, and 316 (81%) received ceftriaxone as initial therapy. Recommendations (n = 107) were accepted in 84%. Pts from both periods were very similar with regard to a variety of characteristics including age, underlying comorbidities, and UTI category (P \> 0.2). Upon completion, therapy was considered appropriate in 150 (74%) PRE pts and 171 (91%) INT pts. Rates of de-escalation of therapy (6% vs 15%, P = 0.006), and subsequent isolation of MDR organisms (i.e., MRSA, VRE, MDR-GNR, and Cdiff; 8% vs. 3%; P = 0.05) were significantly improved during INT. LOS (5 days each), median duration of inpatient therapy (4 days each), readmission rates (12% vs 9%), and mortality (2% vs 1%) did not differ between the two cohorts (P \> 0.2, respectively). However, the subgroup of pts with accepted ASP recommendations had significantly shorter treatment courses (P = 0.02).

***Conclusion.*** ASP activities targeting UTI promoted de-escalation to narrow-spectrum therapy and were associated with decreased MDR rates.
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